Thompson Siegel & Walmsley LLC lessened its stake in The Cigna Group (NYSE:CI – Free Report) by 0.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 53,388 shares of the health services provider’s stock after selling 192 shares during the quarter. Thompson Siegel & Walmsley LLC’s holdings in The Cigna Group were worth $14,981,000 as of its most recent SEC filing.
Other large investors also recently made changes to their positions in the company. Kalos Management Inc. bought a new stake in The Cigna Group in the 1st quarter valued at $27,000. MBM Wealth Consultants LLC bought a new stake in The Cigna Group in the 4th quarter valued at $36,000. Activest Wealth Management bought a new stake in The Cigna Group in the 2nd quarter valued at $34,000. McClarren Financial Advisors Inc. increased its position in The Cigna Group by 672.2% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 139 shares of the health services provider’s stock worth $39,000 after buying an additional 121 shares during the period. Finally, Archer Investment Corp increased its position in The Cigna Group by 1,038.5% during the 2nd quarter. Archer Investment Corp now owns 148 shares of the health services provider’s stock worth $42,000 after buying an additional 135 shares during the period. Institutional investors and hedge funds own 85.32% of the company’s stock.
Analysts Set New Price Targets
CI has been the topic of several recent research reports. Royal Bank of Canada reiterated a “sector perform” rating and set a $327.00 price objective on shares of The Cigna Group in a research report on Wednesday. Wells Fargo & Company raised their price target on The Cigna Group from $284.00 to $300.00 in a research report on Wednesday, August 9th. Edward Jones cut The Cigna Group from a “buy” rating to a “hold” rating in a research report on Thursday, August 17th. Cantor Fitzgerald raised their price target on The Cigna Group from $310.00 to $334.00 and gave the stock a “neutral” rating in a research report on Friday, November 3rd. Finally, StockNews.com upgraded The Cigna Group from a “buy” rating to a “strong-buy” rating in a research report on Friday, November 3rd. Five investment analysts have rated the stock with a hold rating, five have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $336.40.
Insiders Place Their Bets
In other The Cigna Group news, EVP Nicole S. Jones sold 7,819 shares of The Cigna Group stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $276.86, for a total value of $2,164,768.34. Following the completion of the sale, the executive vice president now directly owns 30,069 shares in the company, valued at $8,324,903.34. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, EVP Nicole S. Jones sold 7,819 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $276.86, for a total transaction of $2,164,768.34. Following the completion of the sale, the executive vice president now owns 30,069 shares in the company, valued at $8,324,903.34. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Cynthia Ryan sold 3,768 shares of the business’s stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $282.22, for a total value of $1,063,404.96. Following the sale, the executive vice president now owns 5,503 shares of the company’s stock, valued at approximately $1,553,056.66. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by corporate insiders.
The Cigna Group Trading Up 0.1 %
Shares of CI stock traded up $0.32 during mid-day trading on Friday, reaching $282.56. 1,517,505 shares of the stock traded hands, compared to its average volume of 1,602,673. The stock’s fifty day simple moving average is $294.98 and its two-hundred day simple moving average is $280.99. The Cigna Group has a 1-year low of $240.50 and a 1-year high of $340.11. The company has a market cap of $82.68 billion, a price-to-earnings ratio of 15.94, a price-to-earnings-growth ratio of 1.02 and a beta of 0.65. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.61.
The Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings data on Thursday, November 2nd. The health services provider reported $6.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.68 by $0.09. The Cigna Group had a return on equity of 12.62% and a net margin of 2.79%. The company had revenue of $49.05 billion during the quarter, compared to the consensus estimate of $48.14 billion. During the same period last year, the company earned $6.04 earnings per share. The firm’s revenue was up 8.3% compared to the same quarter last year. On average, research analysts anticipate that The Cigna Group will post 24.82 EPS for the current fiscal year.
The Cigna Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 21st. Shareholders of record on Wednesday, December 6th will be issued a $1.23 dividend. The ex-dividend date is Tuesday, December 5th. This represents a $4.92 dividend on an annualized basis and a yield of 1.74%. The Cigna Group’s payout ratio is currently 27.75%.
The Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
- Five stocks we like better than The Cigna Group
- What Are Dividend Contenders? Investing in Dividend Contenders
- MarketBeat Week in Review – 11/13 – 11/17
- How to Invest in Insurance Companies: A Guide
- 3 large caps with red hot RSIs with upside
- Trading Halts Explained
- Johnson Controls International: Nothing but upside for investors
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.